cancer

ICPO and UroTeragLATAM signed a strategic agreement to accelerate Theranostics for urological cancer in Latin America

The partnership strengthens education, innovation, and patient access by combining global expertise with regional leadership in precision oncology. February 27,…

2 months ago

Manipal Hospital Yeshwanthpur Honors Childhood Cancer Warriors on International Childhood Cancer Day 2026

BENGALURU, India, Feb. 25, 2026 /PRNewswire/ -- In the spirit of Childhood Cancer Day 2026's theme 'Demonstrating Impact: From Challenge to…

2 months ago

Discovery linking gut bacteria to cancer treatment wins the Bial Award in Biomedicine and earns 350,000 prize

A study published in Science reveals that a healthy gut microbiota can enhance the efficacy of immunotherapy used to treat…

2 months ago

Kyntra Bio Announces Positive Data from the Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be Presented at ASCO GU 2026

February 23, 2026 17:10 ET  | Source: Kyntra Bio FG-3246 and enzalutamide combination therapy, in biomarker unselected patients with androgen…

2 months ago

New Guidelines from NCCN Detail Fundamental Differences in Cancer in Children Compared to Adults

National Comprehensive Cancer Network publishes new guidelines for Pediatric Soft Tissue Sarcomas, focused on rhabdomyosarcoma.PLYMOUTH MEETING, Pa., Feb. 17, 2026…

2 months ago

Manipal Hospital Kanakapura Road Commits to Managing Cancer with Compassion and Competence with Comprehensive Cancer Centre (MCCC) Launch

BANGALORE, India, Feb. 6, 2026 /PRNewswire/ -- Strengthening India's fight against cancer, the Manipal Hospitals Group, a trusted name in…

2 months ago

NCCN Commemorates World Cancer Day with New Commitment to Update Patient Resources

The National Comprehensive Cancer Network pledges to update robust information resources for cancer patients and caregivers on an annual basis…

2 months ago

Dewpoint Therapeutics Doses First Patient in Phase 1a/2a Trial DPTX3186 for the Treatment of Advanced Solid Tumors, Focused on Gastric Cancer

DPTX3186, a first-in-class beta-catenin condensate modulator, received Orphan Drug Designation and Fast Track Designation from FDAClinical entry validates condensate modulator…

2 months ago

International Cancer Organizations Work Together to Meet the Needs of Women with Cancer in Vietnam

The National Comprehensive Cancer Network (NCCN) is collaborating with the Vietnam National Cancer Hospital (K Hospital) to adapt regional recommendations…

2 months ago

Curium Announces First Commercial Doses of PYLCLARI for Patients with Prostate Cancer in Poland

PYLCLARI® provides solutions to a wider patient group across Poland where there is high demand and unmet need PARIS, Dec.…

4 months ago